A Phase IV, Open Label Study in Healthy Male Subjects to Investigate the Extent of Darunavir/Ritonavir and Etravirine Exposure in Blood, Seminal Fluid, and Rectal Mucosal Tissue Following Single and Multiple Dosing of Darunavir/Ritonavir and Etravirine.
Phase of Trial: Phase IV
Latest Information Update: 12 May 2011
At a glance
- Drugs Darunavir; Etravirine; Ritonavir
- Indications HIV infections; HIV-1 infections
- Focus Pharmacokinetics
- Acronyms DESeRT
- 12 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Feb 2010 Actual patient number (13) added as reported by ClinicalTrials.gov.
- 05 Feb 2010 Actual initiation date (Jul 2009) added as reported by ClinicalTrials.gov.